Free Trial
NYSE:SYK

Stryker (SYK) Stock Price, News & Analysis

Stryker logo
$393.24 +0.53 (+0.13%)
As of 12:03 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Stryker Stock (NYSE:SYK)

Key Stats

Today's Range
$390.71
$395.05
50-Day Range
$339.96
$394.63
52-Week Range
$314.93
$406.19
Volume
173,644 shs
Average Volume
1.34 million shs
Market Capitalization
$150.10 billion
P/E Ratio
53.09
Dividend Yield
0.85%
Price Target
$427.30
Consensus Rating
Moderate Buy

Company Overview

Stryker Corporation, headquartered in Kalamazoo, Michigan, is a leading global medical technologies company founded in 1941 by Dr. Homer Stryker. Initially known for its innovative hospital bed and mobile frame for medical equipment, the company has grown to serve a broad range of healthcare providers with products and services designed to enhance patient care and operational efficiency.

Stryker operates through three core segments: Orthopedics, MedSurg, and Neurotechnology & Spine. The Orthopedics division focuses on joint replacement, trauma and extremities, and bone cement, delivering implants for hip, knee, shoulder, and extremity reconstruction. The MedSurg segment supplies surgical equipment, endoscopy systems, and communications solutions, while the Neurotechnology & Spine branch offers products for neurological and spinal surgery, including implants, navigation technologies, and surgical instruments.

The company is renowned for its portfolio of advanced medical devices, including robotic surgical systems such as the Mako platform for joint replacement, high-definition endoscopic towers, and hospital infrastructure products like stretchers, beds, and emergency medical equipment. Stryker’s commitment to research and development has led to continual innovation, visible in its minimally invasive surgical tools and digital health solutions that support data-driven clinical decision-making.

With operations in over 100 countries and a workforce spanning multiple continents, Stryker maintains a strong presence across North America, Europe, Asia, and emerging markets. Under the leadership of Chairman and CEO Kevin Lobo, the company continues to expand its global footprint through strategic acquisitions and partnerships, reinforcing its position as a cornerstone in the healthcare industry.

AI Generated. May Contain Errors.

Stryker Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
92nd Percentile Overall Score

SYK MarketRank™: 

Stryker scored higher than 92% of companies evaluated by MarketBeat, and ranked 87th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Stryker has received a consensus rating of Moderate Buy. The company's average rating score is 2.79, and is based on 15 buy ratings, 4 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Stryker has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Stryker's stock forecast and price target.
  • Earnings Growth

    Earnings for Stryker are expected to grow by 10.10% in the coming year, from $13.47 to $14.83 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Stryker is 53.14, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 24.89.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Stryker is 53.14, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 26.51.

  • Price to Earnings Growth Ratio

    Stryker has a PEG Ratio of 2.97. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Stryker has a P/B Ratio of 7.26. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Stryker's valuation and earnings.
  • Percentage of Shares Shorted

    1.43% of the float of Stryker has been sold short.
  • Short Interest Ratio / Days to Cover

    Stryker has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Stryker has recently increased by 2.61%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Stryker has a dividend yield of 0.86%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Stryker has been increasing its dividend for 32 years.

  • Dividend Coverage

    The dividend payout ratio of Stryker is 45.41%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Stryker will have a dividend payout ratio of 22.66% next year. This indicates that Stryker will be able to sustain or increase its dividend.

  • Read more about Stryker's dividend.
  • Percentage of Shares Shorted

    1.43% of the float of Stryker has been sold short.
  • Short Interest Ratio / Days to Cover

    Stryker has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Stryker has recently increased by 2.61%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Stryker has a news sentiment score of 1.37. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.93 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 40 news articles for Stryker this week, compared to 28 articles on an average week.
  • Search Interest

    Only 5 people have searched for SYK on MarketBeat in the last 30 days. This is a decrease of -64% compared to the previous 30 days.
  • MarketBeat Follows

    Only 7 people have added Stryker to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Stryker insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $75,392,000.00 in company stock.

  • Percentage Held by Insiders

    Only 5.90% of the stock of Stryker is held by insiders.

  • Percentage Held by Institutions

    77.09% of the stock of Stryker is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Stryker's insider trading history.
Receive SYK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Stryker and its competitors with MarketBeat's FREE daily newsletter.

SYK Stock News Headlines

Stryker (NYSE:SYK) Stock Rating Lowered by Wall Street Zen
I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
See More Headlines

SYK Stock Analysis - Frequently Asked Questions

Stryker's stock was trading at $360.05 on January 1st, 2025. Since then, SYK stock has increased by 9.2% and is now trading at $393.1210.
View the best growth stocks for 2025 here
.

Stryker Corporation (NYSE:SYK) issued its quarterly earnings results on Thursday, May, 1st. The medical technology company reported $2.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.73 by $0.11. The company's revenue for the quarter was up 11.9% on a year-over-year basis.
Read the conference call transcript
.

Stryker subsidiaries include these companies: Vocera Communications, Vocera, Gauss Surgical, OrthoSensor, Wright Medical Group, Cardan Robotics, Mobius Imaging, and more.

Shares of SYK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Stryker investors own include Broadcom (AVGO), ServiceNow (NOW), BlackRock (BLK), NVIDIA (NVDA), Meta Platforms (META), UnitedHealth Group (UNH) and Advanced Micro Devices (AMD).

Company Calendar

Record date for 4/30 Dividend
3/31/2025
Ex-Dividend for 4/30 Dividend
3/31/2025
Dividend Payable
4/30/2025
Last Earnings
5/01/2025
Today
6/30/2025
Record date for 7/31 Dividend
6/30/2025
Ex-Dividend for 7/31 Dividend
6/30/2025
Next Earnings (Estimated)
7/29/2025
Dividend Payable
7/31/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Health Care Equipment
Current Symbol
NYSE:SYK
Employees
53,000
Year Founded
1941

Price Target and Rating

Average Stock Price Target
$427.30
High Stock Price Target
$456.00
Low Stock Price Target
$370.00
Potential Upside/Downside
+8.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.79
Research Coverage
19 Analysts

Profitability

Trailing P/E Ratio
53.20
Forward P/E Ratio
29.23
P/E Growth
2.97
Net Income
$2.99 billion
Pretax Margin
14.35%

Debt

Sales & Book Value

Annual Sales
$23.22 billion
Cash Flow
$15.09 per share
Price / Cash Flow
26.09
Book Value
$54.13 per share
Price / Book
7.27

Miscellaneous

Free Float
361,841,000
Market Cap
$150.27 billion
Optionable
Optionable
Beta
0.91

Social Links

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (NYSE:SYK) was last updated on 6/30/2025 by MarketBeat.com Staff
From Our Partners